PofoliaShared via Pofolia

JAMA· 2020Q1· Review

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

W. Joost Wiersinga, Andrew Rhodes, Allen Cheng, Sharon J. Peacock et al.

Short summary

Dexamethasone reduced 28-day mortality by 17% in hospitalized COVID-19 patients requiring supplemental oxygen (21.6% vs 24.6%), and remdesivir improved recovery time from 15 to 11 days.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Infectious Diseases

Infectious DiseasesMedicine